Age-related Macular Degeneration - libro nuevo

Libro en la base de datos desde 2012-05-05T02:04:38-05:00 (Mexico City)
Página de detalles modificada por última vez el 2023-09-28T02:54:43-06:00 (Mexico City)
ISBN/EAN: 9783642221071

ISBN - escritura alterna:
3-642-22107-6, 978-3-642-22107-1
Mode alterno de escritura y términos de búsqueda relacionados:
Autor del libro: holz, frank paul, pauleikhoff, bird, frank rich, richard frank, dan richard
Título del libro: degener, degen, macula, degeneration, deg, mac

Datos del la editorial

Autor: Frank G. Holz; Daniel Pauleikhoff; Richard F. Spaide; Alan C. Bird
Título: Age-related Macular Degeneration
Editorial: Springer; Springer Berlin
320 Páginas
Año de publicación: 2012-08-31
Berlin; Heidelberg; DE
Impreso en
Idioma: Inglés
106,99 € (DE)
110,00 € (AT)
130,00 CHF (CH)
Available
XX, 320 p. 132 illus., 80 illus. in color.

EA; E107; eBook; Nonbooks, PBS / Medizin/Klinische Fächer; Augenheilkunde; Verstehen; Eye disease; Macular; Macular Degeneration; Ophthalmology; diabetes; B; Ophthalmology; Geriatrics/Gerontology; Diabetes; Ophthalmology; Geriatrics; Diseases; Medicine; Geriatrie; Krankheiten und Störungen; BB

Age-related macular degeneration is the most common cause for the loss of central vision beyond the age of 50 in industrial nations. Triplication of the number of affected patients is expected over the next 25 years. Especially over the last years the standard of knowledge regarding etiology, risk factors, diagnostics and therapy of this retina illness has substantially grown – this will be covered in this up-to-date multi-authored work. Apart from epidemiologically and genetically identified risk factors both the various pathophysiological aspects including the role of the complement system and clinical manifestations including OCT and angiographic characteristics are clearly represented. Furthermore, the different therapeutic approaches are presented and discussed, including proven procedures such as intravitreal anti-VEGF therapy and seeing-aid systems, in addition to the latest and upcoming methods in the area of pharmacology. The volume is well-illustrated and tables and summaries complete the presentation.

Age-related macular degeneration is the most common cause for the loss of central seeing with humans beyond the age of 50 in the industrial nations. A triplication of the patients is expected in the next 25 years. Especially in the last couple of years the standard of knowledge regarding etiology, risk factors, diagnostics and therapy of this retina illness has substantially grown which is presented in this up-to-date multi-authored work. Apart from epidemiologically identified risk factors both the various pathophysiological aspects and clinical manifestations and angiographic characteristics are clearly represented and in line with standard usage. Furthermore, the different therapeutic approaches are treated, which include proven procedures as laser therapy and seeing-aids systems, in addition to latest methods in the area of the pharmacology, the photo-dynamic therapy, transpupil thermal therapy (TTT) and the macular surgery. The volume is well-illustrated and tables and summaries round up the representation.

Reading Ability.- Magnifying Visual Aids.

From the reviews of the second edition:

“This is an excellent, all-inclusive review of macular degeneration with up-to-date information and good illustrations to help simplify a complex disease. … this book is not only for ophthalmologists and optometrists from the resident level and up, it is also appropriate for basic scientists looking to get the big picture on this disease. … Illustrations are quite good and I found the tables and summaries quite helpful. … This is a high quality book.” (Ayham Skaf, Doody’s Book Reviews, April, 2013)

is Professor of Ophthalmologic Surgery at the University of Bonn, Germany. He is author of many publication, for example within the series Essentials in Ophthalmology.

is Professor of Ophthalmology at the St. Franziskus Hospital in Münster, Germany.

, MD specializes in disease of the retina and vitreous. His particular interest includes retinal surgery, macular degeneration, macular holes, diabetic retinopathy. He is author of numerous books, for example within the Essential in Ophthalmology Series.

is Professor at Moorfields Eye Hospital in London,UK

Age-related macular degeneration has become the most common cause of blindness. With population ageing AMD will become an ever more prevalent cause of visual loss. Here, an expert panel of experienced clinicians and eminent basic scientists provide an authoritative review on the pathogenesis, epidemiology and risk factors, diagnostic methods, imaging modalities and treatment strategies for age-related macular degeneration. Many excellent photographs and diagrams add to a clear understanding.

Updated and enlarged second edition with an authoritative review from an expert panel of clinicians

Strong emphasis on clinical assessment and decision-making

Thorough understanding of the disease which is the common cause of blindness